On the recordDecember 3, 2020
This past July, medical research teams at Israel's Hebrew University in Jerusalem and New York's Mount Sinai Hospital released a study indicating that the FDA-approved cholesterol drug fenofibrate may significantly downgrade the severity of COVID-19. The medical teams were led by Hebrew University Professor Ya'acov Nahmias and Mount Sinai's Dr. Benjamin tenOever. During their research, they found the novel coronavirus and studies conducted on human lung tissue found that COVID-19 prevents the routine burning of carbohydrates, which leads to fat in the lungs, which causes people to die. What happens is that people take fenofibrate, which is a drug that was commonly used for high cholesterol treatment, and it stops this inflammation and improves people's respiratory systems. Right now, these doctors are not given the support they should be given by the CDC and the NIH. We have a lot of people dying of coronavirus, and I think our people should not be too proud to recognize that sometimes cures are made in other countries. I strongly encourage the CDC to look at fenofibrate and these two great researchers. ____________________
